1. Home
  2. MIRA vs LTRY Comparison

MIRA vs LTRY Comparison

Compare MIRA & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • LTRY
  • Stock Information
  • Founded
  • MIRA 2020
  • LTRY 2015
  • Country
  • MIRA United States
  • LTRY United States
  • Employees
  • MIRA N/A
  • LTRY N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • LTRY Computer Software: Prepackaged Software
  • Sector
  • MIRA Health Care
  • LTRY Technology
  • Exchange
  • MIRA Nasdaq
  • LTRY Nasdaq
  • Market Cap
  • MIRA 10.2M
  • LTRY 8.8M
  • IPO Year
  • MIRA 2023
  • LTRY N/A
  • Fundamental
  • Price
  • MIRA $2.36
  • LTRY $1.29
  • Analyst Decision
  • MIRA
  • LTRY
  • Analyst Count
  • MIRA 0
  • LTRY 0
  • Target Price
  • MIRA N/A
  • LTRY N/A
  • AVG Volume (30 Days)
  • MIRA 11.4M
  • LTRY 325.1K
  • Earning Date
  • MIRA 09-13-2024
  • LTRY 08-20-2024
  • Dividend Yield
  • MIRA N/A
  • LTRY N/A
  • EPS Growth
  • MIRA N/A
  • LTRY N/A
  • EPS
  • MIRA N/A
  • LTRY N/A
  • Revenue
  • MIRA N/A
  • LTRY $6,626,564.00
  • Revenue This Year
  • MIRA N/A
  • LTRY N/A
  • Revenue Next Year
  • MIRA N/A
  • LTRY N/A
  • P/E Ratio
  • MIRA N/A
  • LTRY N/A
  • Revenue Growth
  • MIRA N/A
  • LTRY 75.84
  • 52 Week Low
  • MIRA $0.51
  • LTRY $0.82
  • 52 Week High
  • MIRA $6.95
  • LTRY $13.00
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 59.37
  • LTRY 47.82
  • Support Level
  • MIRA $0.62
  • LTRY $1.45
  • Resistance Level
  • MIRA $5.01
  • LTRY $2.20
  • Average True Range (ATR)
  • MIRA 0.57
  • LTRY 0.33
  • MACD
  • MIRA 0.26
  • LTRY 0.07
  • Stochastic Oscillator
  • MIRA 41.07
  • LTRY 33.91

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: